Risk study for non-compaction of the heart muscle
Part of Genetic & congenital, Heart & circulation clinical trials.
This study is for people with a rare heart condition called non-compaction of the ventricular myocardium, where the heart muscle has a spongy appearance. It aims to find better ways to predict risks and prevent complications.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have been diagnosed with non-compaction of the ventricular myocardium (a condition where the heart muscle appears spongy).
- Your diagnosis must be confirmed by at least one of the following: heart ultrasound, EKG, MRI, biopsy, or genetic testing.
- You or your family must agree to join the study and sign a consent form.
- You must have complete medical records available for review.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is for adults who have been diagnosed with a condition called left ventricular non-compaction (LVNC). It aims to find out what might predict future health problems in people with this condition. By joining, you can help researchers learn more about LVNC and improve care for others like you.
This study looks at different types of heart muscle diseases that are not caused by blocked arteries (non-ischemic cardiomyopathies). It aims to better understand how to diagnose, predict outcomes, and treat these conditions by gathering information from many patients over time.
This trial tests an experimental drug called NVC-001 for people with a specific genetic heart condition (LMNA-related dilated cardiomyopathy) that causes the heart to become weak and enlarged. The goal is to see if the drug can help improve heart function.
This study uses heart MRI scans to predict who might develop dangerous heart rhythms. It's for people with certain types of non-ischemic heart disease who have already had an MRI with contrast.
This study uses heart MRI to find people with early signs of heart muscle disease who still have normal-sized heart chambers. It aims to better predict who is at risk so they can get earlier care.
This study looks at the risk of a fast heart rhythm (ventricular tachycardia) in people with genetic heart muscle diseases. It tests whether having a specific genetic change affects the success of a heart ablation procedure.
Hear when a new Isolated Noncompaction of the Ventricular Myocardium trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.